EUVIMEDEUVIMED entdecken
Open Access

LC ‐ OCT for early diagnosis and characterization of dermatologic adverse events to oncologic drugs and correlation to histopathology

Pietro Sollena iD, Marisa Salvi, Marica Marraffa, Luca Pellegrino, Simone Cappilli iD, Gerardo Palmisano, Maria Mannino, Lucia Di Nardo, Alessandro Di Stefani, Ketty Peris

International Journal of Dermatology · 2025

DOI: 10.1111/ijd.17520 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Dermatology, 2025. Verfasst von Pietro Sollena und 9 weiteren Autor:innen. Beteiligte Einrichtung: UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Tomography, Optical Coherence, Drug Eruptions, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Targeted and immune therapies have recently been associated with the occurrence of multiple cutaneous toxicities, often challenging to differentiate by clinical examination alone without histology. Line‐field confocal optical coherence tomography (LC‐OCT) is a non‐invasive and innovative imaging technique that has been shown to be almost as effective as histology in diagnosing several skin conditions. Our study aimed to assess the effectiveness of LC‐OCT in predicting the clinical evolution of early maculopapular eruptions related to antineoplastic targeted therapy and immunotherapy.

Methods

In the period between May 2023 and December 2023, consecutive patients with clinical cutaneous maculopapular reactions caused by oncologic targeted therapy or immunotherapy were enrolled at the dermatologic outpatient clinic of the Fondazione Policlinico A. Gemelli IRCCS, Rome. Patients underwent clinical dermatological examination, video‐dermoscopy, LC‐OCT, and incisional skin biopsy of a target cutaneous lesion. To investigate the evolutionary pattern of maculopapular lesions (psoriasic eruption, lichenoid eruption, eczematous eruption, bullous eruption), LC‐OCT and histopathological images have been compared based on specific characteristics (hyperkeratosis, acanthosis, spongiosis; papillomatosis; lichenoid inflammatory infiltrate; presence of intraepidermal/subepidermal cleavage plan with formation of a bulla).

Results

Eighteen patients were included in this study (11 males, 7 females, median age 64.5). LC‐OCT demonstrated an overall concordance with histology of 77.8%, with a Cohen's Kappa of 0.69 ( P < 0.0001). Sensitivity exceeded 70%, and specificity was ≥88.2%. The Area Under the Curve (AUC) ranged from 0.9 to 1 for psoriasis and lichenoid eruption and from 0.7 to 0.9 for eczematous and bullous eruption.

Conclusions

LC‐OCT appears to be a promising tool for the early differential diagnosis of adverse skin reactions related to targeted therapy and immunotherapy, offering the potential to avoid skin biopsies in fragile cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tomography, Optical CoherenceDrug EruptionsAntineoplastic AgentsHumansFemaleMaleMiddle AgedAgedSkinEarly DiagnosisAdultBiopsyDermoscopyAged, 80 and overImmunotherapy

Stichwörter der Autor:innen

cutaneous adverse eventshistopathologyline‐field confocal optical coherence tomographyoncologic treatments

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Rome, Italy.
  • Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica Del Sacro Cuore, Rome, Italy.

ORCID-Profile: Pietro Sollena, Simone Cappilli

Zitieren

APA

Sollena, P., Salvi, M., Marraffa, M., Pellegrino, L., Cappilli, S., Palmisano, G., Mannino, M., Di Nardo, L., Di Stefani, A., & Peris, K. (2025). LC ‐ OCT for early diagnosis and characterization of dermatologic adverse events to oncologic drugs and correlation to histopathology. International Journal of Dermatology. https://doi.org/10.1111/ijd.17520

Vancouver

Sollena P, Salvi M, Marraffa M, Pellegrino L, Cappilli S, Palmisano G, et al. LC ‐ OCT for early diagnosis and characterization of dermatologic adverse events to oncologic drugs and correlation to histopathology. International Journal of Dermatology. 2025. doi:10.1111/ijd.17520

BibTeX
@article{Sollena2025,
  author = {Sollena, Pietro and Salvi, Marisa and Marraffa, Marica and Pellegrino, Luca and Cappilli, Simone and Palmisano, Gerardo and Mannino, Maria and Di Nardo, Lucia and Di Stefani, Alessandro and Peris, Ketty},
  title = {LC ‐ OCT for early diagnosis and characterization of dermatologic adverse events to oncologic drugs and correlation to histopathology},
  journal = {International Journal of Dermatology},
  year = {2025},
  doi = {10.1111/ijd.17520}
}
Kostenlos starten →